Disclosure of shareholdings – Holta Invest AS (2025)

03. Mar 2025 | 1 min read

3 March 2025

Holta Invest AS has today sold 1,228,502 shares in Gentian Diagnostics ASA and holds after this transaction no longer any shares in Gentian Diagnostics ASA.

Consequently, Holta Invest AS has passed the 5% threshold pursuant to Section 4-2 (1) of the Norwegian Securities Trading Act.

This information is subject to the disclosure requirements pursuant to Section 4-2 and 5-12 of the Norwegian Securities Trading Act

You may also read


Nov 11, 2025 - Ole Sørlie

Financial calendar

Financial calendar for Gentian Diagnostics ASA

Oct 23, 2025 - Ole Sørlie

Study Confirms the Value of Calprotectin in Early Detection of Neonatal Infections and Sepsis

Belgrade, October 23, 2025 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..